We found significantly higher circulating sclerostin levels in the newly diagnosed type 2 diabetes male individuals compared to the healthy male control group and it was corroborating with SOST mRNA expression (Figure 2B). The gene discussed is SOST; the disease is type 2 diabetes mellitus.